Tan and colleagues suggest that the aberrant Runx2 expression and osteomimetic behavior observed in bone metastatic breast cancer is a consequence of epithelial to mesenchymal transition (EMT) [62]. This evidence concerns the gene RUNX2 and breast carcinoma.